Decision Diagnostics Corp (DECN)

[rawman]

All OTC tickers whether they are stop sign, yield sign, Grey or expert market must comply with SEC rule by June 30th or lose quoting so they are all rushing to become Pink Current again, and so is DECN

The above relates to two different unconnected issues!

Filing a current quarterly report does not automatically make the company "Pink Current". OTC Markets makes the decision to remove the Caveat Emptor designation, with a current report not being the sole qualification. Keep in mind, DECN has posted quarterly reports, since being suspended by the SEC, but the Caveat Emptor designation remains. The Attorney Letter has no bearing on the CE situation! It is simply a normal procedure for those choosing to file an annual financial report, using the Alternative Reporting Standard.

The scramble caused by the SEC is specifically related to the new SEC disclosure amendment that was delivered last September. It has nothing to do with being Caveat Emptor. The new SEC Disclosure Rule is specific to ANY OTC company, Pink or otherwise, which is deemed delinquent in reporting Material Events and quarterly financial information. A current financial report does not remove the CE designation, but it does remove the SEC's disclosure scrutiny.